Grifols signs $3.4bn Talecris loans
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
SecuritizationCLOs

Grifols signs $3.4bn Talecris loans

Spanish healthcare company Grifols has signed the loan agreements backing its takeover of US biotherapy and biotechnology company Talecris, after an oversubscribed syndication phase. High yield bonds worth $1.1bn will be issued in the next few weeks.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Related articles

Gift this article